معرفی
Dr. Polly Gravells serves as a University Teaching Associate at the School of Biosciences, University of Sheffield, where she joined in 2021 after a decade-long association with the institution. Her academic journey includes completing a PhD in Cancer Studies at the University of Sheffield Medical School in 2010, followed by post-doctoral research at Imperial College London and a return to Sheffield in 2013.
Her educational background features:
- PhD in Cancer Studies, University of Sheffield (2010)
Dr. Gravells' research centers on molecular mechanisms of DNA repair and cell cycle regulation, with particular emphasis on homologous recombination pathways. She investigates how defects in these processes can be exploited to develop novel therapeutic strategies for rare cancers, bridging fundamental molecular biology with clinical oncology applications. Her work has significant implications for targeted cancer treatments.
Analysis of her publication record reveals consistent focus on DNA repair deficiencies in rare malignancies like uveal melanoma and neuroblastoma. Key trends include exploration of replication stress mechanisms, comparative efficacy of PARG versus PARP inhibitors, and synthetic lethality approaches for cancers with specific DNA repair defects. Her research demonstrates translational potential in radiosensitization and targeted therapy development.
Professional recognition:
- Senior Fellow of the Higher Education Authority
Dr. Gravells actively contributes to biomedical science education through molecular biology instruction on undergraduate programmes, cancer/genetic instability modules at advanced levels, and practical skills laboratory sessions. No information is available regarding graduate student supervision or research grant acquisition.
She maintains active research within the School of Biosciences, focusing on molecular oncology and DNA repair pathways with direct relevance to developing novel cancer therapeutics for underserved patient populations.
